Nano Drug Delivery Systems for Colon Cancer

Arun Kumar Singh holds an M.Pharm in Pharmaceutics from Galgotias University, India, and serves as an Assistant Professor in the Department of Pharmacy at Vivekanand Global University. He is actively engaged in teaching and interdisciplinary research spanning nano-formulation, artificial intelligence, machine learning, big data analytics, IoT, blockchain, cancer biology, and neuroscience.Mr. Singh has made substantial scholarly contributions, authoring one book with IOP Publishing, five book chapters with River Publishers, and 28 review articles in reputed journals, including high-impact publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. In addition, he has authored and edited 58 books with leading publishers such as Elsevier, CRC Press, and Wiley. Known for his research acumen and leadership, Mr. Singh is committed to advancing pharmaceutical sciences through innovation and interdisciplinary collaboration, with a focus on impactful healthcare solutions.Dr. Vipan Kumar is an Associate Professor at the School of Pharmaceutical Sciences, CGC University, Mohali, India. He received his PhD in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak, India, where he was awarded fellowship support from the University Grants Commission (UGC), New Delhi. Dr. Kumar’s research focuses on medicinal chemistry, nanotechnology-based drug delivery, and the development of novel therapeutic agents for cancer and metabolic disorders. Dr. Kumar has published over 35 research and review articles in peer-reviewed national and international journals and has authored and edited 04 national and international books, along with several book chapters. He also holds 04 Indian patents in the areas of drug discovery and nanomedicine. His academic achievements have been recognized with several honors, including the Backbone Award (2025–26) from CGC University, Mohali, and the Devi Lal Memorial Award (2020–21) from JCD Vidyapeeth, Sirsa, for excellence in teaching and research. Dr. Kumar serves on the editorial boards of multiple international journals and acts as a reviewer for several reputed publications. He has delivered more than 30 oral and poster presentations at national and international scientific meetings and actively contributes to academic governance and policy development through his roles in ethical committees, inspection teams, examination committees, and university Boards of Studies.Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.Dr Meenakshi Dhanawat, is currently working as Associate Professor in Amity Institute of Pharmacy, Amity University Haryana. She has a background in Pharmaceutical Sciences with a specialization in Medicinal Chemistry. She has done Masters from NIPER, Mohali and the project was based on Glycosylamino acids. Her PhD is from IIT-BHU, Varanasi and she worked on CNS drug delivery targeting 5HT1A/2A receptor. Apart from that she has a vast experience in the extraction of herbal drugs. Area of interest are Synthetic Chemistry, Heterocyclic Chemistry, Nanotechnology, Drug Delivery, Prodrug and Co-Drug Drug Design Complexation, Polymer Chemistry, and their application in drug delivery.She has 17 years of teaching and research experience. She has attended several national and international conferences in india and abroad the recipient of the travelship award in DDD section of AAPS-2010, National Biotechnology Conference, California, USA. She has been able to grab the international travel grant from DBT and DST for attending the International Conference at California, USA and Munich, Germany Respectively. She has also grabbed many other fellowships awards, which includes Rajiv Gandhi National Fellowship. She has Published more than 85 Research/Reviews along with Patent-06, Books 6, Book Chapter 22, Book Editor 02, Copyright 01.Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has extensive teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for cancer and neurodegenerative disorders. His research interests focus on advanced pharmaceutical formulations and controlled delivery approaches aimed at improving therapeutic outcomes.Dr. Mishra has supervised postgraduate and doctoral research scholars and has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He is also associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, research, and pharmaceutical education. He has additionally been recognized internationally for his research impact and scholarly contributions in the field of pharmaceutical sciences.

• 1. Etiology and pathophysiology of colon cancer2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents10. Surface modified Metal Nanoparticles in Colon Cancer Therapy11. Nano-based Phyto drug delivery systems for the management of colon cancer12. Role of polymeric nanoparticles for the treatment of Colon cancer13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer14. Regulatory framework in the Nanomedicine targeting Colon Cancer15. Current and future perspectives of nanomedicine in colon cancer treatment